Medios AG
Medios AG, together with its subsidiaries, supplies specialty pharmaceutical drugs primarily in Germany. The company operates through three segments: Patient-Specific Therapies; International Business; and Pharmaceutical Supply. The Patient-Specific Therapies segment manufactures medications for patients on behalf of pharmacies. This segment includes cytostatic preparations, antibody therapies, a… Read more
Medios AG (MEDOF) - Net Assets
Latest net assets as of September 2025: $518.11 Million USD
Based on the latest financial reports, Medios AG (MEDOF) has net assets worth $518.11 Million USD as of September 2025.
Net assets (also known as shareholders' equity or book value) represent the difference between a company's total assets ($939.33 Million) and total liabilities ($421.22 Million). This figure indicates the residual interest in the assets after deducting liabilities, essentially showing what would remain for shareholders if all assets were liquidated and all debts paid off.
Key Net Assets Metrics
| Metric | Value |
|---|---|
| Current Net Assets | $518.11 Million |
| % of Total Assets | 55.16% |
| Annual Growth Rate | 32.63% |
| 5-Year Change | 258.22% |
| 10-Year Change | 157475.61% |
| Growth Volatility | 2686.54 |
Medios AG - Net Assets Trend (2009–2024)
This chart illustrates how Medios AG's net assets have evolved over time, based on quarterly financial data. Explore and compare other companies by net assets.
Annual Net Assets for Medios AG (2009–2024)
The table below shows the annual net assets of Medios AG from 2009 to 2024.
| Year | Net Assets | Change |
|---|---|---|
| 2024-12-31 | $510.19 Million | +8.83% |
| 2023-12-31 | $468.81 Million | +4.63% |
| 2022-12-31 | $448.05 Million | +13.67% |
| 2021-12-31 | $394.16 Million | +176.75% |
| 2020-12-31 | $142.43 Million | +74.48% |
| 2019-12-31 | $81.63 Million | +15.79% |
| 2018-12-31 | $70.50 Million | +54.34% |
| 2017-12-31 | $45.68 Million | +33.95% |
| 2016-12-31 | $34.10 Million | +10431.51% |
| 2015-12-31 | $323.78K | -- |
| 2014-12-31 | $0.00 | -- |
| 2013-12-31 | $7.81K | -95.49% |
| 2012-12-31 | $172.97K | -54.09% |
| 2011-12-31 | $376.75K | +10.46% |
| 2010-12-31 | $341.07K | -95.38% |
| 2009-12-31 | $7.38 Million | -- |
Equity Component Analysis
This analysis shows how different components contribute to Medios AG's total equity over time. Equity components include common stock, retained earnings, additional paid-in capital, and other elements.
Equity Composition Insights
- Retained earnings have grown by 7840300000.0% over the analyzed period, indicating profitable operations and earnings retention.
Current Equity Component Breakdown (December 2024)
| Component | Amount | Percentage |
|---|---|---|
| Retained Earnings | $78.40 Million | 15.37% |
| Common Stock | $25.51 Million | 5.00% |
| Other Components | $406.28 Million | 79.63% |
| Total Equity | $510.19 Million | 100.00% |
Medios AG Competitors by Market Cap
The table below lists competitors of Medios AG ranked by their market capitalization.
| Company | Market Cap |
|---|---|
|
The ODP Corporation
MX:ODP
|
$466.85 Million |
|
DroneShield Limited
PINK:DRSHF
|
$467.01 Million |
|
Farmland Partners Inc
NYSE:FPI
|
$467.58 Million |
|
Varex Imaging Corp
NASDAQ:VREX
|
$467.60 Million |
|
Retailors Ltd
PINK:RTALF
|
$466.70 Million |
|
Distoken Acquisition Corporation Right
NASDAQ:DISTR
|
$466.59 Million |
|
Dark Horse Beijing Technology Co Ltd
SHE:300688
|
$465.91 Million |
|
First Tractor Company Limited
PINK:FIRRF
|
$465.88 Million |
Equity Growth Attribution
This analysis shows how different factors contributed to changes in Medios AG's equity between the two most recent reporting periods.
Equity Growth Insights
- From 2023 to 2024, total equity changed from 468,807,000 to 510,192,000, a change of 41,385,000 (8.8%).
- Net income of 12,548,000 contributed positively to equity growth.
- Other factors increased equity by 28,837,000.
Equity Change Factors (2023 to 2024)
| Factor | Impact | Contribution |
|---|---|---|
| Net Income | $12.55 Million | +2.46% |
| Other Changes | $28.84 Million | +5.65% |
| Total Change | $- | 8.83% |
Book Value vs Market Value Analysis
This analysis compares Medios AG's book value (net assets) with its market value over time. The relationship between these values can provide insights into investor sentiment and company valuation.
Valuation Insights
- Current price-to-book ratio: 2.50x
- The company is trading above its book value, indicating the market recognizes value beyond its reported assets.
- The price-to-book ratio has decreased from 66.78x to 2.50x over the analyzed period, indicating reduced market premium.
Historical Price-to-Book Ratios
| Date | Book Value per Share | Market Price | P/B Ratio |
|---|---|---|---|
| 2010-12-31 | $0.75 | $50.00 | x |
| 2011-12-31 | $0.83 | $50.00 | x |
| 2012-12-31 | $0.41 | $50.00 | x |
| 2013-12-31 | $0.02 | $50.00 | x |
| 2015-12-31 | $0.71 | $50.00 | x |
| 2016-12-31 | $7.38 | $50.00 | x |
| 2017-12-31 | $3.58 | $50.00 | x |
| 2018-12-31 | $5.00 | $50.00 | x |
| 2019-12-31 | $5.47 | $50.00 | x |
| 2020-12-31 | $8.90 | $50.00 | x |
| 2021-12-31 | $19.55 | $50.00 | x |
| 2022-12-31 | $18.77 | $50.00 | x |
| 2023-12-31 | $19.69 | $50.00 | x |
| 2024-12-31 | $20.00 | $50.00 | x |
Capital Efficiency Dashboard
This dashboard shows how efficiently Medios AG utilizes its equity to generate returns, including Return on Equity (ROE) and its components based on the DuPont analysis framework.
Capital Efficiency Insights
- Current Return on Equity (ROE): 2.46%
- The company may be facing challenges in efficiently utilizing shareholder equity.
- DuPont Analysis Breakdown:
- • Net Profit Margin: 0.67%
- • Asset Turnover: 2.02x
- • Equity Multiplier: 1.83x
- Recent ROE (2.46%) is above the historical average (-187.48%), indicating improving capital efficiency.
Historical Capital Efficiency Metrics
| Year | Return on Equity | Net Profit Margin | Asset Turnover | Equity Multiplier | Economic Value Added |
|---|---|---|---|---|---|
| 2012 | -117.82% | -578.54% | 0.08x | 2.55x | $-221.08K |
| 2013 | -2115.86% | -50645.54% | 0.00x | 30.02x | $-165.94K |
| 2015 | -49.68% | -119388.59% | 0.00x | 1.57x | $-193.24K |
| 2016 | -9.87% | -2.38% | 2.78x | 1.49x | $-6.38 Million |
| 2017 | 9.05% | 1.63% | 4.11x | 1.35x | $-433.32K |
| 2018 | 6.14% | 1.32% | 3.33x | 1.40x | $-2.72 Million |
| 2019 | 11.96% | 1.89% | 4.43x | 1.43x | $1.60 Million |
| 2020 | 3.88% | 0.88% | 3.22x | 1.37x | $-8.72 Million |
| 2021 | 1.88% | 0.55% | 2.59x | 1.33x | $-32.01 Million |
| 2022 | 4.09% | 1.14% | 2.80x | 1.29x | $-26.48 Million |
| 2023 | 4.01% | 1.05% | 3.00x | 1.27x | $-28.07 Million |
| 2024 | 2.46% | 0.67% | 2.02x | 1.83x | $-38.47 Million |
Industry Comparison
This section compares Medios AG's net assets metrics with peer companies in the Medical Distribution industry.
Industry Context
- Industry: Medical Distribution
- Average net assets among peers: $1,254,633,395
- Average return on equity (ROE) among peers: -3.66%
Peer Company Comparison
| Company | Net Assets | Return on Equity | Debt-to-Equity | Market Cap |
|---|---|---|---|---|
| Medios AG (MEDOF) | $518.11 Million | -117.82% | 0.81x | $466.82 Million |
| Accendra Health Inc (ACH) | $314.40 Million | 8.91% | 1.75x | $22.90K |
| Arjo AB (publ) (ARRJF) | $6.88 Billion | 10.78% | 1.12x | $491.29 Million |
| Cardinal Health Inc (CAH) | $255.60 Million | 13.15% | 1.57x | $50.81 Billion |
| Cencora Inc. (COR) | $4.01 Billion | 11.02% | 2.01x | $62.31 Billion |
| Cosmos Health Inc. (COSM) | $36.04 Million | -51.45% | 0.83x | $8.90 Million |
| EDAP TMS SA (EDAP) | $50.05 Million | 1.40% | 0.54x | $115.72 Million |
| Empro Group Inc. Ordinary shares (EMPG) | $741.21K | -42.90% | 4.10x | $9.16 Million |
| Energy Management International Inc (ENMI) | $-362.21K | 0.00% | 0.00x | $383.13K |
| Exlites Holdings International Inc (EXHI) | $-84.27 | 0.00% | 0.00x | $574.58K |
| Galenica AG (GALNF) | $999.54 Million | 12.50% | 1.21x | $3.75 Billion |